Cardiac Success

Company Overview

Snapshot

Founded in August 2017 by David Neustadter, Cardiac Success operates with 1–10 employees. The company has secured funding across three rounds, totaling $6.82 million from three investors.

Business overview

Cardiac Success is a Health Tech & Life Sciences company developing the V-sling, a transcatheter ventricular repair device. This medical device is designed to improve the lives of patients experiencing heart failure with reduced ejection fraction (HFrEF) despite receiving guidance-directed medical therapy. The V-sling's design is based on a successful surgical papillary muscle approximation procedure, targeting the cardiology market and serving healthcare providers and patients.

Strategic signal

This strategic investment from a prominent European investor signals strong validation for Cardiac Success's V-sling technology and its potential to address a critical need in heart failure treatment, indicating a positive trajectory for product development and market entry.

Company Intelligence Q&A

What is Cardiac Success's primary product?

Cardiac Success is developing the V-sling, a transcatheter ventricular repair device designed to improve outcomes for patients with heart failure with reduced ejection fraction (HFrEF).

When was Cardiac Success founded?

Cardiac Success was founded in August 2017.

Who is a co-founder of Cardiac Success?

David Neustadter is a co-founder and CTO of Cardiac Success.

Which investor participated in Cardiac Success's June 2021 Series A financing?

In June 2021, 415 Capital participated in Cardiac Success's Series A financing.